Mazor Robotics Ltd  

(Public, OTCMKTS:MZRTF)   Watch this stock  
Find more results for PINK:MZRTF
+0.53 (4.95%)
Jul 29 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 10.67 - 11.45
52 week 4.25 - 11.45
Open 10.92
Vol / Avg. 1,768.00/846.00
Mkt cap 2.00B
P/E     -
Div/yield     -
EPS     -
Shares 44.61M
Beta 1.88
Inst. own     -
Aug 17, 2016
Q2 2016 Mazor Robotics Ltd Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Jul 19, 2016
Mazor Robotics Ltd Extraordinary Shareholders Meeting
Jul 12, 2016
Mazor Robotics Ltd Analyst and Investor Day "Platforms and Model for Accelerated Growth" - Webcast
May 23, 2016
Mazor Robotics Ltd at UBS Global Healthcare Conference
May 18, 2016
Mazor Robotics Ltd Signs Strategic Commercial and Investment Agreements With Medtronic Corporate Call
May 10, 2016
Q1 2016 Mazor Robotics Ltd Earnings Release
May 10, 2016
Q1 2016 Mazor Robotics Ltd Earnings Call

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin -79.64% -58.96%
Operating margin -81.35% -58.66%
EBITD margin - -56.64%
Return on average assets -41.85% -25.25%
Return on average equity -50.53% -28.89%
Employees 141 -
CDP Score - -


7 HaEshel St., Caesarea Park South PO Box 3104
CAESAREA, 3088900
+972-4-6187100 (Phone)
+972-4-6187111 (Fax)

Website links


Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications. Its Renaissance System and its predecessor are used in a number of spine surgeries, including fusion, correction of spinal deformities, biopsy collection, tumor excision and cement augmentations. Furthermore the Company developed the Renaissance Brain Module, an application of its Renaissance System that provides control over the insertion of surgical instruments during brain surgery.

Officers and directors

Jonathan Adereth Chairman of the Board
Age: 66
Ori Hadomi Chief Executive Officer, Director
Age: 47
Sharon Levita Chief Financial Officer, Secretary
Age: 45
Eliyahu Zahavi Chief Operating Officer
Age: 58
Moshe Shoham Chief Technology Officer
Age: 63
Sandra Adzic Vice President of International Sales
Anat Kaphan Vice President of Marketing and Product Management
Doron Dinstein Chief Medical Officer
Age: 42
Michael Berman Director
Age: 57
Sarit Sukari Soccary Ben-Yochanan Director
Age: 41